| pubmed-article:12825134 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12825134 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:12825134 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:12825134 | lifeskim:mentions | umls-concept:C0205476 | lld:lifeskim |
| pubmed-article:12825134 | lifeskim:mentions | umls-concept:C0008312 | lld:lifeskim |
| pubmed-article:12825134 | lifeskim:mentions | umls-concept:C0005330 | lld:lifeskim |
| pubmed-article:12825134 | lifeskim:mentions | umls-concept:C0449445 | lld:lifeskim |
| pubmed-article:12825134 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:12825134 | pubmed:dateCreated | 2003-6-25 | lld:pubmed |
| pubmed-article:12825134 | pubmed:abstractText | A new medical approach to primary biliary cirrhosis (PBC) has been desired. We investigated the feasibility of using combination ursodeoxycholic acid (UDCA)-bezafibrate therapy in patients with PBC nonresponsive to UDCA monotherapy. | lld:pubmed |
| pubmed-article:12825134 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12825134 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12825134 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12825134 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12825134 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12825134 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12825134 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12825134 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12825134 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12825134 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12825134 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12825134 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12825134 | pubmed:issn | 0944-1174 | lld:pubmed |
| pubmed-article:12825134 | pubmed:author | pubmed-author:SaishoHiromit... | lld:pubmed |
| pubmed-article:12825134 | pubmed:author | pubmed-author:KandaTatsuoT | lld:pubmed |
| pubmed-article:12825134 | pubmed:author | pubmed-author:YokosukaOsamu... | lld:pubmed |
| pubmed-article:12825134 | pubmed:author | pubmed-author:ImazekiFumioF | lld:pubmed |
| pubmed-article:12825134 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12825134 | pubmed:volume | 38 | lld:pubmed |
| pubmed-article:12825134 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12825134 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12825134 | pubmed:pagination | 573-8 | lld:pubmed |
| pubmed-article:12825134 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:12825134 | pubmed:meshHeading | pubmed-meshheading:12825134... | lld:pubmed |
| pubmed-article:12825134 | pubmed:meshHeading | pubmed-meshheading:12825134... | lld:pubmed |
| pubmed-article:12825134 | pubmed:meshHeading | pubmed-meshheading:12825134... | lld:pubmed |
| pubmed-article:12825134 | pubmed:meshHeading | pubmed-meshheading:12825134... | lld:pubmed |
| pubmed-article:12825134 | pubmed:meshHeading | pubmed-meshheading:12825134... | lld:pubmed |
| pubmed-article:12825134 | pubmed:meshHeading | pubmed-meshheading:12825134... | lld:pubmed |
| pubmed-article:12825134 | pubmed:meshHeading | pubmed-meshheading:12825134... | lld:pubmed |
| pubmed-article:12825134 | pubmed:meshHeading | pubmed-meshheading:12825134... | lld:pubmed |
| pubmed-article:12825134 | pubmed:meshHeading | pubmed-meshheading:12825134... | lld:pubmed |
| pubmed-article:12825134 | pubmed:meshHeading | pubmed-meshheading:12825134... | lld:pubmed |
| pubmed-article:12825134 | pubmed:meshHeading | pubmed-meshheading:12825134... | lld:pubmed |
| pubmed-article:12825134 | pubmed:meshHeading | pubmed-meshheading:12825134... | lld:pubmed |
| pubmed-article:12825134 | pubmed:meshHeading | pubmed-meshheading:12825134... | lld:pubmed |
| pubmed-article:12825134 | pubmed:meshHeading | pubmed-meshheading:12825134... | lld:pubmed |
| pubmed-article:12825134 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12825134 | pubmed:articleTitle | Bezafibrate treatment: a new medical approach for PBC patients? | lld:pubmed |
| pubmed-article:12825134 | pubmed:affiliation | First Department of Medicine, Chiba University School of Medicine, Japan. | lld:pubmed |
| pubmed-article:12825134 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12825134 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12825134 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12825134 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12825134 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12825134 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12825134 | lld:pubmed |
